Logo for AroCell

AroCell Investor Relations Material

Latest events

Logo for AroCell

Q4 2024

19 Feb, 2025
Logo for AroCell

Q3 2024

24 Oct, 2024
Access the full event backlog
Slides, Transcripts, and Reports from 12,000+ public companies

Latest reports from AroCell

Access all reports
AroCell AB is a Swedish diagnostics company that develops and markets blood and urine sample tests primarily for monitoring cancer, particularly breast, prostate, and bladder cancers. Its main product is the AroCell TK 210 ELISA, an immunoassay kit that measures Thymidine Kinase 1 protein levels in blood samples, helping to assess cell proliferation in cancer patients. Another key product, UBC Rapid, is used for diagnosing and monitoring bladder cancer. AroCell is headquartered in Stockholm, Sweden, and its shares are listed on the Stockholm Stock Exchange.